Antralization at the edge of proximal gastric ulcers: Does Helicobacter pylori infection play a role?

World Journal of Gastroenterology

Volumn 9, Issue 6, 2003, Pages 1265-1269

  Xia, Harry Hua Xinag ^a   Lam, Shiu Kum ^a   Wong, Wai Man ^a   Hu, Wayne Hsing Cheng ^a   Lai, Kam Chuen ^a   Wong, Sau Hing ^a   Leung, Suet Yi ^a   Yuen, Siu Tsan ^a   Wright, Nicholas A ^b   Wong, Benjamin Chun Yu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Cancer Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; SUCRALFATE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREVALENCE; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH FUNDUS; STOMACH MUCOSA; STOMACH ULCER;

EID: 0037713705     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i6.1265     Document Type: Article

References (35)

1. Westbrook JI, Rushworth RL. The epidemiology of peptic ulcer mortality 1953-1989: A birth cohort analysis. Int J Epidemiol 1993; 22: 1085-1092
2. Anonymous. NIH Concensus Conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-69
3. Xia HHX, Wong BCY, Wong KW, Wong KW, Wong SY, Wong WM, Lai KC, Hu WHC, Chan CK, Lam SK. Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: A long-term prospective study. Aliment Pharmacol Ther 2001; 15: 1875-1882
4. Xia HHX, Phung N, Kalantar JS, Talley NJ. Demographic and endoscopic characteristics of Helicobacter pylori-positive and negative peptic ulcer disease. Med J Aust 2000; 173: 515-519
5. Carrick J, Lee A, Hazell S, Ralston M, Daskalopoulos G. Campylobacter pylori, duodenal ulcer, and gastric metaplasia: Possible role of functional heterotopic tissue in ulcerogenesis. Gut 1989; 30: 790-797
6. Taha AS, Dahill S, Nakshabendi I, Lee FD, Sturrock RD, Russell RI. Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs. Gut 1993; 34: 1162-1166
7. Olbe L, Fandriks L, Hamlet A, Svennerholm AM. Conceivable mechanisms by which Helicobacter pylori provokes duodenal ulcer disease. Best Pract Res Clin Gastroenterol 2000; 14: 1-12
8. Longman RJ, Douthwaite J, Sylvester PA, Poulsom R, Corfield AP, Thomas MG, Wright NA. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 2000; 47: 792-800
9. Pera M, Heppell J, Poulsom R, Teixeira FV, Williams J. Ulcer associated cell lineage glands expressing trefoil peptide genes are induced by chronic ulceration in ileal pouch mucosa. Gut 2001; 48: 792-796
10. Hanby AM, Jankowski JA, Elia G, Poulsom R, Wright NA. Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barrett's metaplasia and the native oesophageal epithelium: Delineation of epithelial phenotype. J Pathol 1994; 173: 213-219
11. Wright NA, Poulsom R, Stamp GW, Hall PA, Jeffery RE, Longcroft JM, Rio MC, Tomasetto C, Chambon P. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990; 162: 279-284
12. Roberts IS, Stoddart RW. Ulcer-associated cell lineage ('pylori metaplasia') in Crohn's disease: A lectin histochemical study. J Pathol 1993; 171: 13-19
13. Callea F, Sergi C, Fabbretti G, Brisigotti M, Cozzutto C, Medicina D. Precancerous lesions of the biliary tree. J Surg Oncol 1993; 3(Suppl): 131-133
14. Sasaki M, Yamato T, Nakanuma Y, Ho SB, Kim YS. Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non-dysplastic epithelia of the gallbladder. Pathol Inter 1999; 49: 38-44
15. Yamagiwa H. Mucosal dysplasia of gallbladder: Isolated and adjacent lesions to carcinoma. Jpn J Cancer Res 1989; 80: 238-243
16. Bakotic BW, Robinson MJ, Sturm PD, Hruban RH, Offerhaus GJ, Albores-Saavedra J. Pylori gland adenoma of the main pancreatic duct. Am J Surg Pathol 1999; 23: 227-231
17. Dixon MF. Atrophy, metaplasia and dysplasia - A risk for gastric cancer: Are they reversible? In: Hunt R, Tytgat G, editors. Helicobacter Pylori. Basic Mechanisms to Clinical Cure. Lancaster: Kluwer 1998; pp336-353
18. Xia HHX, Kalantar J, Talley NJ, Ma Wyatt J, Adams S, Cheung K. Antral-type mucosa in the gastric incisura (antralization) - A link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol 2000; 95: 114-121
19. Xia HHX, Zhang G-S, Talley NJ, Wong BC, Yang Y, Henwood C, Wyatt JM, Adams S, Cheung K, Xia B, Zhu YQ, Lam SK. Topographic association of gastric epithelial expression of Ki-67, Bax and Bcl-2 expression with antralization in the gastric incisura, body and fundus. Am J Gastroenterol 2002; 97: 3123-3131
20. Wong BCY, Wong WM, Wang WH, Wang WH, Tang VSY, Young J, Lai KC, Yuen ST, Leung SY, Hu WHC, Chan CK, Hui WM, Lam SK. An evaluation of invasive and non-invasive tests for the diagnosis of Helicobacter pylori infection in Chinese. Aliment Pharmacol Ther 2001; 15: 505-511
21. Dixon MF, Genta RM, Yardley JH, Correa P. And the participants in the International Workshop on the Histopathology of Gastritis, Houston 1994. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996; 20: 1161-1181
22. Xia HHX, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: Implications in gastric carcinogenesis. Am J Gastroenterol 2001; 96: 16-26
23. Hanby AM, Poulsom R, Playford RJ, Wright NA. The mucous neck cell in the human gastric corpus: A distinctive, functional cell lineage. J Pathol 1999; 187: 331-337
24. Schmidt PH, Lee JR, Joshi V, Playford RJ, Poulsom R, Wright NA, Goldenring JR. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 1999; 79: 639-646
25. Wright NA. Mechanisms involved in gastric atrophy. In: Hunt R, Tytgat G, editors. Helicobacter Pylori. Basic Mechanisms to Clinical Cure 2000. Dordrecht: Kluwer 2000; pp239-247
26. Dixon MF. Patterns of inflammation linked to ulcer disease. Best Pract Res Clin Gastroenterol 2000; 14: 27-40
27. Sipponen P, Kimura K. Intestinal metaplasia, atrophic gastritis and stomach cancer: Trends over time. Eur J Gastroenterol Hepatol 1994; 6 (Suppl 1): S79-S83
28. Sakaki N, Kozawa H, Egawa N, Tu Y, Sanaka M. Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings. Aliment Pharmacol Ther 2002; 16(Suppl 2): 198-203
29. Seery JP. A reinterpretation of the events in gastric carcinogenesis. Med Hypoth 1991; 35: 179-181
30. Genta RM. Atrophy, metaplasia and dysplasia: Are they reversible? Ital J Gastroenterol Hepatol 1998; 30(Suppl 3): S324-S325
31. Satoh K. Does eradication of Helicobacter pylori reverse atrophic gastritis or intestinal metaplasia? Data from Japan. Gastroenterol Clin North Am 2000; 29: 829-835
32. Dixon MF. Prospects for intervention in gastric carcinogenesis: Reversibility of gastric atrophy and intestinal metaplasia. Gut 2001; 49: 2-4
33. Xia HHX, Wong BCY, Lam SK. Helicobacter pylori infection and gastric cancer. Asian J Surg 2001; 24: 217-221
34. Lanas A, Sekar C, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992; 103: 862-869
35. Lanas A, Serano P, Bajador E, Esteva F, Benito R, Sainz R. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology 1997; 112: 683-689